trans-ISRIB #75845
Product Information
Product Usage Information
trans-ISRIB is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.11 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.
Storage
Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.
Product Description
| Molecular Weight | 451.3 g/mol |
| Purity | >98% |
| Molecular Formula | C22H24Cl2N2O4 |
| CAS | 1597403-47-8 |
| Solubility | Soluble in DMSO at 5 mg/mL. |
Background
Trans-integrated stress response inhibitor (trans-ISRIB) is a small-molecule inhibitor of the cellular integrated stress response (ISR). The ISR is a coordinated collection of signaling pathways that activate different eukaryotic initiation factor 2 (eIF2) kinases to phosphorylate the subunit eIF2α. trans-ISRIB strongly (IC50 = 5 nM) reverses the effects of eIF2α phosphorylation in cells undergoing ISR (1). Phosphorylation of eIF2α stabilizes and inhibits turnover of the eIF2β protein complex (2). Both trans-ISRIB and eIF2(αP) bind to distinct sites within the guanine nucleotide exchange factor eIF2β. trans-ISRIB inhibits the ISR by promoting eIF2β nucleotide exchange activity and antagonizing the inhibitory effect of eIF2(αP) on eIF2β activity. Simultaneous binding of eIF2(αP) to eIF2β regulatory sites deforms the trans-ISRIB-binding pocket and prevents trans-ISRIB inhibition of the ISR (3). Because heightened ISR is sometimes associated with unfavorable outcomes, trans-ISRIB treatment can provide beneficial effects in models of neurodegeneration, chronic demyelination, and head injury (4-6).
- Sidrauski, C. et al. (2013) Elife 2, e00498.
- Pavitt, G.D. (2005) Biochem Soc Trans 33, 1487-92.
- Zyryanova, A.F. et al. (2021) Mol Cell 81, 88-103.e6.
- Halliday, M. et al. (2015) Cell Death Dis 6, e1672.
- Wong, Y.L. et al. (2018) Elife 7, e32733. doi: 10.7554/eLife.32733.
- Chou, A. et al. (2017) Proc Natl Acad Sci U S A 114, E6420-E6426.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意，否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件，除非书 CST 的合法授书代表以书面形式书独接受， 否书均被拒书，并且无效。
专品专有“专供研究使用”的专专或专似的专专声明， 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的， 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专，且专用于研专用途。将专品用于专断、专防或治专目的， 或专专售（专独或作专专成）或其他商专目的而专专专品，均需要 CST 的专独专可。客专：(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品，或使用专品制造任何商专专品，(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专，或使用专品开专任何与 CST 的专品或服专专争的专品或服专， (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专，(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品， (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.